CASE REPORT
Accepted on 31 Jan 2025
Disitamab Vedotin combined with Pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report
doi 10.3389/fphar.2025.1431422
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- The Molecular Mechanism in Anti-tumor Therapy Resistance
The Molecular Mechanism in Anti-tumor Therapy Resistance
3,893
Total downloads
13k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Accepted on 27 Dec 2024
The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
doi 10.3389/fphar.2024.1437022
- 430 views
ORIGINAL RESEARCH
Published on 18 Dec 2024
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
doi 10.3389/fphar.2024.1464852
- 571 views
REVIEW
Published on 25 Nov 2024
Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer
doi 10.3389/fonc.2024.1481777
- 678 views
REVIEW
Published on 16 Sep 2024
HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
doi 10.3389/fphar.2024.1446414
- 1,755 views
REVIEW
Published on 06 Sep 2024
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy
doi 10.3389/fphar.2024.1450203
- 1,139 views
- 1 citation
ORIGINAL RESEARCH
Published on 04 Sep 2024
PFKFB3 deprivation attenuates the cisplatin resistance via blocking its autophagic elimination in colorectal cancer cells
doi 10.3389/fphar.2024.1433137
- 703 views
CASE REPORT
Published on 29 Aug 2024
A novel secondary ALK gene mutation which resistant to second-generation TKIs: a case report and literature review
doi 10.3389/fonc.2024.1430350
- 577 views
REVIEW
Published on 26 Aug 2024
DNA damage response-related ncRNAs as regulators of therapy resistance in cancer
doi 10.3389/fphar.2024.1390300
- 845 views
ORIGINAL RESEARCH
Published on 23 Jul 2024
RREB1-mediated SUMOylation enhancement promotes chemoresistance partially by transcriptionally upregulating UBC9 in colorectal cancer
doi 10.3389/fphar.2024.1381860
- 815 views
REVIEW
Published on 22 Jul 2024
Prospects of compounds of herbal plants as anticancer agents: a comprehensive review from molecular pathways
doi 10.3389/fphar.2024.1387866
- 2,097 views
- 2 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 13kTopic views
- 8,213Article views
- 3,893Article downloads